With Biotech IPOs Booming, Here Are 2 To Watch
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
This clinical-stage biopharmaceutical company focused on developing treatments for different kinds of cancers just recently launched an IPO, making it just the second IPO to…